Sylvamo director granted 3,876 RSUs

Desmond Jeanmarie F. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Desmond Jeanmarie F. reported acquisition or exercise transactions in this Form 4 filing.

Sylvamo Corp director Desmond Jeanmarie F. received a grant of 3,876 shares of Common Stock in the form of time-based restricted stock units as compensation for board service for the 2026-2027 performance year. These RSUs were valued at $38.70 per share for reporting purposes.

The RSUs will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting. The director has elected to defer settlement of any vested RSUs until the first to occur of May 13, 2032, or the end of her service as a director. After this award, she directly holds 16,734 shares of Sylvamo stock.

Insider Trade Summary

Grant/Award: 3,876 shares

Grant/Award 1 txn

Insider Desmond Jeanmarie F.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,876	$38.70	$150K

Holdings After Transaction: Common Stock — 16,734 shares (Direct)

Footnotes (1)

1. F1. The reported securities represent time-based restricted stock units ("RSUs") that were granted to the reporting person for service as a director for the 2026-2027 performance year and that will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting. The reporting person has elected to defer settlement of vested RSUs until the first to occur of May 13, 2032, or the termination of her service as a director.

Key Figures

RSU grant size: 3,876 shares Grant valuation price: $38.70 per share Post-transaction holdings: 16,734 shares +2 more

5 metrics

RSU grant size 3,876 shares Time-based RSUs for 2026-2027 performance year

Grant valuation price $38.70 per share Value used for RSU grant reporting

Post-transaction holdings 16,734 shares Total Sylvamo common shares held directly after grant

RSU vesting date May 13, 2027 Vests earlier of this date or next annual shareowners meeting

Deferral settlement date May 13, 2032 Latest date for settlement unless director service ends earlier

Key Terms

restricted stock units ("RSUs"), vest, defer settlement, performance year

4 terms

restricted stock units ("RSUs") financial

"The reported securities represent time-based restricted stock units ("RSUs") that were granted to the reporting person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vest financial

"that will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

defer settlement financial

"The reporting person has elected to defer settlement of vested RSUs until the first to occur of May 13, 2032"

performance year financial

"granted to the reporting person for service as a director for the 2026-2027 performance year"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Sylvamo (SLVM) report for director Desmond Jeanmarie F.?

Sylvamo reported that director Desmond Jeanmarie F. received 3,876 time-based restricted stock units as an equity award. The grant compensates her for service during the 2026-2027 performance year and increases her direct holdings to 16,734 Sylvamo common shares after the transaction.

How many Sylvamo (SLVM) shares were granted in the latest Form 4 filing?

The Form 4 shows a grant of 3,876 restricted stock units tied to Sylvamo common stock. These RSUs are valued at $38.70 per share for reporting and represent additional equity compensation rather than an open-market purchase or sale by the reporting director.

What are the vesting terms of the new Sylvamo (SLVM) RSU award?

The 3,876 restricted stock units will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting. Vesting means the director earns full rights to the shares, subject to her separate election to defer actual share settlement to a later date.

When will the Sylvamo (SLVM) director receive shares from the RSU grant?

Although the RSUs may vest as early as May 13, 2027, the director elected to defer settlement. Shares from vested RSUs will be delivered at the first to occur of May 13, 2032, or when her service as a Sylvamo director terminates.

How many Sylvamo (SLVM) shares does the director hold after this RSU grant?

Following the RSU award, the director is reported to directly own 16,734 Sylvamo common shares. This total reflects the addition of 3,876 restricted stock units reported in the filing, which function as stock-based compensation for her board service.

Was the Sylvamo (SLVM) Form 4 transaction an open-market stock purchase or sale?

No, the Form 4 reports a grant classified as an acquisition under code A, not an open-market trade. The 3,876 units are restricted stock units awarded as compensation, with vesting conditions and a separate deferral election governing when shares are actually delivered.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 11:55 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Desmond Jeanmarie F.

(Last) (First) (Middle)

6077 PRIMACY PARKWAY

(Street)

MEMPHIS TENNESSEE 38119

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sylvamo Corp [ SLVM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/15/2026		A		3,876	A(1)	$38.7	16,734	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reported securities represent time-based restricted stock units ("RSUs") that were granted to the reporting person for service as a director for the 2026-2027 performance year and that will vest upon the earlier of May 13, 2027, or the next annual shareowners meeting. The reporting person has elected to defer settlement of vested RSUs until the first to occur of May 13, 2032, or the termination of her service as a director.

Remarks:

	/s/ Erin Raccah, attorney in fact for Jeanmarie F. Desmond	05/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)